Circassia Pharmaceuticals PLC Company Profile (LON:CIR)

About Circassia Pharmaceuticals PLC (LON:CIR)

Circassia Pharmaceuticals PLC logoCircassia Pharmaceuticals plc is a specialty biopharmaceutical company focused on allergy and respiratory diseases. The Company operates through three segments: Allergy, which relates to a range of immunotherapy development products for the treatment of allergy; NIOX, which relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO), and Respiratory, which relates to the portfolio of asthma and chronic obstructive pulmonary disease product candidates. Its next-generation immunotherapy is in Phase III testing for cat allergy. Its lead asthma treatment targets substitution of GlaxoSmithKline's (GSK's) Flixotide pMDI. It is developing therapies targeting direct substitution of Seretide pMDI and Serevent pMDI. The Company is also developing a range treatment, including a fixed dose triple combination containing an inhaled corticosteroid, long-acting beta agonist and long-acting muscarinic antagonist.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: LON:CIR
  • CUSIP: N/A
  • Web: N/A
Capitalization:
  • Market Cap: £266.83 million
  • Outstanding Shares: 284,622,000
Average Prices:
  • 50 Day Moving Avg: GBX 99.03
  • 200 Day Moving Avg: GBX 92.54
  • 52 Week Range: GBX 78.45 - GBX 278.60
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: £23.1 million
  • Price / Sales: 11.55
  • Book Value: GBX 0.99 per share
  • Price / Book: 0.95
Profitability:
  • EBIDTA: ($66,300,000.00)
Misc:
  • Average Volume: 163,922 shs.
 

Frequently Asked Questions for Circassia Pharmaceuticals PLC (LON:CIR)

What is Circassia Pharmaceuticals PLC's stock symbol?

Circassia Pharmaceuticals PLC trades on the London Stock Exchange (LON) under the ticker symbol "CIR."

Where is Circassia Pharmaceuticals PLC's stock going? Where will Circassia Pharmaceuticals PLC's stock price be in 2017?

6 equities research analysts have issued 1-year price objectives for Circassia Pharmaceuticals PLC's stock. Their predictions range from GBX 105 to GBX 174. On average, they anticipate Circassia Pharmaceuticals PLC's stock price to reach GBX 141.50 in the next year. View Analyst Ratings for Circassia Pharmaceuticals PLC.

Who are some of Circassia Pharmaceuticals PLC's key competitors?

How do I buy Circassia Pharmaceuticals PLC stock?

Shares of Circassia Pharmaceuticals PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

How much does a share of Circassia Pharmaceuticals PLC stock cost?

One share of Circassia Pharmaceuticals PLC stock can currently be purchased for approximately GBX 93.75.

Analyst Ratings

Consensus Ratings for Circassia Pharmaceuticals PLC (LON:CIR) (?)
Ratings Breakdown: 3 Hold Ratings, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: GBX 141.50

Analysts' Ratings History for Circassia Pharmaceuticals PLC (LON:CIR)
Show:
DateFirmActionRatingPrice TargetDetails
5/26/2017Numis Securities LtdReiterated RatingBuyGBX 174View Rating Details
5/23/2017JPMorgan Chase & Co.Reiterated RatingNeutralGBX 120View Rating Details
4/26/2017Peel HuntDowngradeHoldGBX 150 -> GBX 130View Rating Details
4/25/2017Stifel NicolausReiterated RatingBuyGBX 150View Rating Details
6/21/2016Barclays PLCInitiated CoverageOverweightGBX 410 -> GBX 170View Rating Details
6/21/2016Royal Bank of CanadaDowngradeSector PerformerGBX 430 -> GBX 105View Rating Details
(Data available from 5/27/2015 forward)

Earnings

Earnings History for Circassia Pharmaceuticals PLC (LON:CIR)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Circassia Pharmaceuticals PLC (LON:CIR)
Current Year EPS Consensus Estimate: $-35.39 EPS

Dividends

Dividend History for Circassia Pharmaceuticals PLC (LON:CIR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Circassia Pharmaceuticals PLC (LON:CIR)
Insider Trades by Quarter for Circassia Pharmaceuticals PLC (LON:CIR)
Insider Trades by Quarter for Circassia Pharmaceuticals PLC (LON:CIR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/18/2015Swingland,CharlesInsiderSell754,548GBX 320£2,414,553.60
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Circassia Pharmaceuticals PLC (LON:CIR)
Latest Headlines for Circassia Pharmaceuticals PLC (LON:CIR)
Source:
DateHeadline
americanbankingnews.com logoCircassia Pharmaceuticals PLC (CIR) Earns "Buy" Rating from Numis Securities Ltd
www.americanbankingnews.com - May 26 at 7:14 AM
americanbankingnews.com logoCircassia Pharmaceuticals PLC (CIR) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - May 16 at 9:46 AM
finance.yahoo.com logoCircassia Pharmaceuticals Plc – Value Analysis (LONDON:CIR) : May 12, 2017
finance.yahoo.com - May 12 at 9:54 PM
finance.yahoo.com logoCircassia Pharmaceuticals Plc breached its 50 day moving average in a Bearish Manner : CIR-GB : May 11, 2017
finance.yahoo.com - May 11 at 4:57 PM
reuters.com logoBRIEF-Circassia Pharmaceuticals fy revenues increased to 23.1 mln stg
www.reuters.com - April 26 at 9:50 PM
finance.yahoo.com logo[$$] Circassia losses at widen after failed clinical trials
finance.yahoo.com - April 26 at 9:50 PM
americanbankingnews.com logoStifel Nicolaus Reiterates Buy Rating for Circassia Pharmaceuticals PLC (CIR)
www.americanbankingnews.com - April 25 at 7:07 AM
americanbankingnews.com logoCircassia Pharmaceuticals PLC (CIR) Rating Reiterated by JPMorgan Chase & Co.
www.americanbankingnews.com - April 23 at 9:56 PM
americanbankingnews.com logoCircassia Pharmaceuticals PLC (CIR) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - April 21 at 9:53 AM
morningstar.co.uk logoCircassia Gets Early Termination Of Waiting Period In AstraZeneca Deal
www.morningstar.co.uk - April 11 at 11:24 AM
americanbankingnews.com logoCircassia Pharmaceuticals PLC (CIR) Earns "Buy" Rating from Stifel Nicolaus
www.americanbankingnews.com - April 8 at 6:08 PM
americanbankingnews.com logoCircassia Pharmaceuticals PLC (CIR) Stock Rating Reaffirmed by JPMorgan Chase & Co.
www.americanbankingnews.com - April 1 at 12:25 PM
americanbankingnews.com logoCircassia Pharmaceuticals PLC (CIR) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - March 27 at 1:50 PM
americanbankingnews.com logoCircassia Pharmaceuticals PLC's (CIR) "Neutral" Rating Reaffirmed at JPMorgan Chase & Co.
www.americanbankingnews.com - March 24 at 4:21 AM
americanbankingnews.com logoCircassia Pharmaceuticals PLC (CIR) Upgraded by Stifel Nicolaus to "Buy"
www.americanbankingnews.com - March 20 at 12:34 PM
americanbankingnews.com logoCircassia Pharmaceuticals PLC (CIR) Set to Announce Quarterly Earnings on Monday
www.americanbankingnews.com - March 17 at 9:06 PM
bloomberg.com logoWoodford-Backed Biopharma Stock Circassia Surges on Astra Pact
www.bloomberg.com - March 17 at 3:47 PM
bizjournals.com logo$230M deal: AstraZeneca forms COPD drugs collaboration
www.bizjournals.com - March 17 at 3:47 PM
finanznachrichten.de logoINVESCO PERPETUAL SELECT TRUST PLC - Half-year Report
www.finanznachrichten.de - February 1 at 4:38 PM
lse.co.uk logoTotal Voting Rights Update - London South East (registration) (blog)
www.lse.co.uk - December 1 at 4:28 PM
reuters.com logoUK Stocks-Factors to watch on Sept. 27
www.reuters.com - September 27 at 8:49 AM
biz.yahoo.com logoHalf Year 2016 Circassia Pharmaceuticals PLC Earnings Release - Time Not Supplied
biz.yahoo.com - September 27 at 8:49 AM

Social

Social activity is not available for this stock.

Chart

Circassia Pharmaceuticals PLC (CIR) Chart for Saturday, May, 27, 2017

This page was last updated on 5/27/2017 by MarketBeat.com Staff